163 related articles for article (PubMed ID: 7299393)
21. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
Beart PM; Krstich M; McDonald D; Gundlach AL
Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of D2 dopamine receptors in different brain regions.
Leonard MN; Macey CA; Strange PG
Biochem J; 1987 Dec; 248(2):595-602. PubMed ID: 2963621
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 3H-spiperone binding in caudate nuclei of rabbits and rats.
Hernandez LL; Powell DA
Pharmacol Biochem Behav; 1987 Feb; 26(2):253-8. PubMed ID: 3575350
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
George SR; Watanabe M; Seeman P
J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
[TBL] [Abstract][Full Text] [Related]
25. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
Gundlach AL; Krstich M; Beart PM
Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
[TBL] [Abstract][Full Text] [Related]
26. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
[No Abstract] [Full Text] [Related]
27. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
Marchais D; Tassin JP; Bockaert J
Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
[No Abstract] [Full Text] [Related]
28. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
Bischoff S; Bittiger H; Krauss J
Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
[TBL] [Abstract][Full Text] [Related]
29. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Quik M; Spokes EG; Mackay AV; Bannister R
J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
[TBL] [Abstract][Full Text] [Related]
30. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
[No Abstract] [Full Text] [Related]
31. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
[TBL] [Abstract][Full Text] [Related]
32. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
Varmuza S; Mishra RK
Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
[No Abstract] [Full Text] [Related]
33. Identity and properties of multiple neuroleptic-binding sites in rat limbic brain areas [proceedings].
Leysen JE
Arch Int Physiol Biochim; 1979 Oct; 87(4):822-4. PubMed ID: 93926
[No Abstract] [Full Text] [Related]
34. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
Howlett DR; Nahorski SR
Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
[No Abstract] [Full Text] [Related]
35. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
Quik M; Bergeron L; Mount H; Philie J
Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
[TBL] [Abstract][Full Text] [Related]
36. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
Near JA; Mahler HR
Neurochem Res; 1982 Jul; 7(7):831-7. PubMed ID: 7121724
[TBL] [Abstract][Full Text] [Related]
37. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
De Vries DJ; Beart PM
Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
[TBL] [Abstract][Full Text] [Related]
38. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
39. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain.
Moroi K; Ozaki N; Kadota T; Kadota K
Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654
[TBL] [Abstract][Full Text] [Related]
40. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]